Clinical Trial Update: AMTEC IIT: Phase 2 Multiarm Study in TNBC [Phase 2]

View source ↗

Summary

Phase 2 multiarm AMTEC IIT trial in metastatic/triple-negative breast cancer has been terminated; results have been posted on 2025-11-21.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Gordon Mills, MD, PhD | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-11-21